GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
68 hedge funds and large institutions have $470M invested in Global Blood Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
58% less capital invested
Capital invested by funds: $1.12B → $470M (-$648M)
Holders
68
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$22.6M | |
| 2 | +$14.7M | |
| 3 | +$10.2M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$9.6M |
| 5 |
DM
Deerfield Management
New York
|
+$8.83M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$6.81M | |
| 3 | -$6.15M | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$3.7M |
| 5 |
Millennium Management
New York
|
-$3.04M |